Hi twinpeaks....not sure if I am reading your post incorrectly...but you mentioned... "It would seem counterintuitive for a biotechnology index to require trial success before they will allow a company to list."
Are you suggesting that PRR has applied, as part of their nasdaq listing, to be listed in the biotechnology index?
To list in this index one of the requirements is that the company has a minimum market cap of $200 mil.
If this is the case then this maybe is the reason we have not listed as yet.
I thought the application was to list on the nasdaq, and not specifically in the index.
See the link below and scroll down to the "Biotechnology Index Security Eligibility Criteria" and dot point 4.
http://www.nasdaq.com/dynamic/nasdaqbiotech_activity.stm
Cheers
Hi twinpeaks....not sure if I am reading your post...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 53192 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 41048 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |